Physician profile
Hector Castillo
NPI 1659366136
$1,609.94
in general payments reported to CMS, 2019-2025
20 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $137 · 2021: $156 · 2022: $78.04 · 2023: $146 · 2024: $379 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $719.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $338.61 | 2019-2025 | Vraylar |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $249.23 | 2019 | |
| Depuy Synthes Sales INC. | $231.55 | 2024 | Na |
| Novartis Pharmaceuticals Corporation | $153.37 | 2019-2023 | |
| Pfizer INC. | $118.56 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.77 | 2024-2025 | |
| Abbott Laboratories | $75.56 | 2021-2023 | Freestyle Libre 2, Freestyle Libre 3 |
| Novo Nordisk INC | $72.92 | 2019-2023 | Wegovy |
| Lilly USA, LLC | $69.69 | 2019-2023 | Jardiance, Lyumjev, Baqsimi |
| E.R. Squibb & Sons, L.L.C. | $28.06 | 2019-2020 | |
| Medtronic, INC. | $27.19 | 2021 | |
| Glaxosmithkline, LLC. | $25.33 | 2024 | Trelegy Ellipta |
| Genentech USA, INC. | $23.55 | 2020 | |
| Sanofi-Aventis U.S. LLC | $21.18 | 2019 | |
| Janssen Pharmaceuticals, INC | $18.75 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.55 | 2024 | Jardiance |
| Amgen INC. | $14.81 | 2025 | Krystexxa |
| Merck Sharp & Dohme LLC | $14.34 | 2019 | |
| Zealand Pharma US, INC. | $13.93 | 2022 | |
| Cequr Corporation | $12.99 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hector Castillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.